Welcome to the April edition of the Burjeel Holdings Feat Focus Newsletter. This month, we continued to drive healthcare transformation through innovations, strategic expansions, and patient-centric clinical advancements that reflect our vision for smarter, faster, and more compassionate care.

Marking a milestone in our efforts to reshape the healthcare landscape, we unveiled our integrated innovation ecosystem at Abu Dhabi Global Health Week. We forged transformational global collaborations, such as making CAR-T Cell Therapy—a life-saving cancer treatment—more affordable through local manufacturing. We have also partnered to introduce multilingual, empathy-driven agents to deliver real-time, culturally aware support across a wide range of patient touchpoints.

In KSA, we expanded our presence through strategic collaborations, reinforcing our role in strengthening healthcare access in the region.

The month also witnessed the announcement of the Suite Ride initiative in partnership with Axiom Space to explore diabetes management in microgravity. At BMC, we opened three specialized units—the Genetics and Rare Diseases Center, the Breast Center, and the Advanced Epilepsy Monitoring Unit—to offer patients access to advanced diagnostics and tailored treatments.

In Hungary, Prof. Amulya Saxena, Consultant Pediatric Surgeon at Burjeel Hospital, Abu Dhabi, led a complex surgical intervention for a young boy born with a rare and severe congenital condition. This successful international collaboration highlighted the global impact of our clinical expertise and the spirit of compassionate care that defines Burjeel Holdings.

Read the full newsletter here to learn more.

Burjeel Drives Healthcare Innovation in April: Read Feat Focus